GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - June 13, 2000JAMC - le 13 juin 2000

Briefly . . .

CMAJ 2000;162:1731


Worst asthma symptoms caused by prostaglandin D2

The mechanism behind asthma is under increasing scrutiny. In asthma, environmental antigens trigger immunoglobulin E antibodies, which then activate mast cells. These mast cells release substances that induce inflammation. Experiments with genetically engineered mice now show that one of these inflammation-inducing substances — prostaglandin D2 — is responsible for the worst symptoms of asthma (Science 2000;287:2013-7). When the gene for prostaglandin D2 receptors was removed from asthmatic mice, they did not experience the hyper-reactive airways typical of asthma. Future therapies targeting prostaglandin D2 could mitigate asthma's life-threatening complications.

Comments Send a letter to the editor
Envoyez une lettre à la rédaction


Pathologic protein gives fruit flies Parkinson's disease

Researchers have created fruit flies with Parkinson's disease — one of the few animal models of the disease, and proof that a mutant protein leads to the neural degeneration in the disease (Nature 2000;404:394-8). They now hope that the flies will show how the protein works, and provide a testing ground for new therapies. The researchers genetically engineered Drosophila melanogaster to express mutated -synuclein, a protein found in abundance in nerves, whose function is unknown. Two mutations in genes that encode -synuclein were recently found in families with inherited Parkinson's disease, leading to research into the protein. The fruit flies with mutated proteins have physical signs of Parkinson's disease — progressive loss of dopamine-secreting neurons and intracellular aggregates resembling Lewy bodies — as well as behavioural characteristics. The flies failed a standard vial-climbing test, indicating locomotor defects.

Comments Send a letter to the editor
Envoyez une lettre à la rédaction

© 2000 Canadian Medical Association or its licensors